Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

Last updated:
2026-07-25
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

COMBINATION CEFAZOLIN WITH ERTAPENEM FOR METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BACTEREMIA (CERT)

Intervention/treatment:
ERTAPENEM
Medical condition:
BACTEREMIA
Protocol code:
2021-7400
Control number:
259270
Status:
Recruiting
Approved:
January 04, 2022
Trial phase:
Phase 2
For more information:
ClinicalTrials.gov - NCT04886284
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years to 100 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Lina Petrella
Role
CONTACT
Phone:
514-934-1934
Extension 23730
Sponsor
RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE

Locations

Alberta

Foothills Medical Centre
Calgary, Alberta, T2N4Z6
RECRUITING
Name
Ranjani Somayaji, MD MPH
Role
PRINCIPAL_INVESTIGATOR

Ontario

Hamilton Health Sciences (Hamilton General Hospital and Juravinski Hospital)
Hamilton, Ontario, L8P1A2
RECRUITING
Name
Dominik Mertz, MD MSc
Role
PRINCIPAL_INVESTIGATOR
Niagara Health - St. Catharines site
Saint Catharines, Ontario, L2E6X2
RECRUITING
Name
Aidan Findlater, MD
Role
PRINCIPAL_INVESTIGATOR

Quebec

Hospital de la Cité de la Sante
Laval, Quebec, T2N4Z6
RECRUITING
Name
Marco Bergevin, MD
Role
CONTACT
Name
Marco Bergevin, MD
Role
PRINCIPAL_INVESTIGATOR
Jewish General Hospital
Montreal, Quebec, H3T 1E2
RECRUITING
Name
Leighanne Parkes, MD
Role
PRINCIPAL_INVESTIGATOR
Phone:
514-934-1934
Extension 23730
McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital)
Montreal, Quebec, H4A3J1
RECRUITING
Name
Lina Petrella
Role
CONTACT
Phone:
514-934-1934
Extension 23730
Name
Emily G McDonald, MD MSc
Role
PRINCIPAL_INVESTIGATOR
Name
Todd C Lee, MD MPH FIDSA
Role
PRINCIPAL_INVESTIGATOR
Name
Cheng P Matthew, MD
Role
PRINCIPAL_INVESTIGATOR
Name
Guillaume Butler-Laporte, MD
Role
SUB_INVESTIGATOR
Name
Alexander Lawandi, MD MSc
Role
SUB_INVESTIGATOR
Did you find what you were looking for?

Contacts and resources